Subject: Re: [AUDITORY] preprints, community journals, and the carbon footprint of hearing healthcare From: kno <"Baskent, D "> Date: Mon, 7 Nov 2022 12:41:32 +0000--_000_PA4PR09MB4589C44F07DF831AC1D3018EE43C9PA4PR09MB4589eurp_ Content-Type: text/plain; charset="windows-1250" Content-Transfer-Encoding: quoted-printable Beste Jan-Willem, all, This is a great discussion. It is very timely, addressing many important to= pics in one go. For pre-registration and pre-printing: I agree that it is a great way to make known of a specific study and its re= lated hypotheses. This goes very well with open science principles. But we = did have suffer from pre-prints that have not made their way to a peer-revi= ewed publication because during a peer-review some substantial shortcomings= were identified. Similarly, we also have identified many times very import= ant shortcomings of our own studies/papers during peer-review, and at those= times we were happy we did not have a pre-print. Perhaps the best way to u= se them is to find out who works on what, but perhaps one should check with= the authors that the status is for the peer-review of a pre-print before w= anting to cite it. Having said that, especially for articles like yours, it would be great to = have a medium for opinion pieces. We did use one of these pre-registration = sites for this purpose, and once in awhile some journals (Frontiers?) also = allow articles like these. About the carbon foot-print article: Very nice ideas! Having been in the fields of hearing aids and cochlear imp= lants for many years, I also have always wondered why the rechargeable batt= eries have not become that popular. Especially implant users have to rely o= n their batteries and if they use disposable ones, they need to remember to= take many of them around to not find themselves without their implant func= tioning. Maybe also relevant: sometimes new device features or new approaches to sig= nal processing do not lead to an advantage in perception, but still produce= a benefit in power consumption. Sometimes such ideas are discarded, but an= ything that can lead to a longer battery life would be an important benefit= for any device user. Best wishes and groet, Deniz -------------------------- Prof. dr. ir. D. Ba=BAkent Speech Perception Lab (dB SPL) Department of Otorhinolaryngology School of Behavioral and Cognitive Neuroscience (BCN) W.J. Kolff Institute for Biomedical Engineering and Materials Science University Medical Center Groningen (UMCG) University of Groningen (RUG) Tel: +31 (0) 50 3612540 (KNO Office) Visiting address: UMCG, Hanzeplein 1, Room P3.202 Website (also for dB SPL): dbaskent.org<http://dbaskent.org> ________________________________ From: AUDITORY - Research in Auditory Perception <AUDITORY@xxxxxxxx>= on behalf of Wasmann, Jan-Willem <Jan-Willem.Wasmann@xxxxxxxx> Sent: 07 November 2022 6:42 To: AUDITORY@xxxxxxxx <AUDITORY@xxxxxxxx> Subject: Re: preprints, community journals, and the carbon footprint of hea= ring healthcare Dear Raul, goede morgen Alejandro and Bill, Thank you for sharing these insights. Raul you shared a number of platforms that are new to me. Alejandro, it helps a lot that you shared your strategy and the different g= oals that you chase per platform. I like the GitHub integration of Zenodo. = I will digest this to revise my publishing strategy and will share it later= here if people are interested. Further suggestions are still welcome. Bill shared some insights regarding the carbon footprint of chip design, re= -use of medical devices and waste. Meanwhile, our little article/blog appeared here. We got excellent support = from the editors by the way from the Hearing Tracker and were glad we were = able to publish it before the COP27 started. https://www.hearingtracker.com/news/carbon-footprint-of-hearing-healthcare<= https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fwww.hea= ringtracker.com%2Fnews%2Fcarbon-footprint-of-hearing-healthcare&data=3D05%7= C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f4= 4d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d8e= yJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C= %7C%7C&sdata=3DZ9HjE5dJ00xk3NUiymMSv5OnCLehyR8OrfjiJ2lG23A%3D&reserved=3D0> [https://a.storyblok.com/f/45415/1200x675/c1db8bc00d/earth-and-carbon-footp= rint-hearing-aid-industry_1200x675.jpg]<https://eur03.safelinks.protection.= outlook.com/?url=3Dhttps%3A%2F%2Fwww.hearingtracker.com%2Fnews%2Fcarbon-foo= tprint-of-hearing-healthcare&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548d= e03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C6380= 33970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIi= LCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DZ9HjE5dJ00xk3NUiymMS= v5OnCLehyR8OrfjiJ2lG23A%3D&reserved=3D0> The Carbon Footprint of Hearing Healthcare and How to Reduce It<https://eur= 03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fwww.hearingtracker= .com%2Fnews%2Fcarbon-footprint-of-hearing-healthcare&data=3D05%7C01%7Cd.bas= kent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6= dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4w= LjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdat= a=3DZ9HjE5dJ00xk3NUiymMSv5OnCLehyR8OrfjiJ2lG23A%3D&reserved=3D0> The global carbon footprint of medicine is about 5% of global CO 2 emission= s. 1-3 This is quite a chunk of our carbon budget to stay within 1.5=B0 C (= 2.7=B0F) of global warming, especially in light that many people globally h= ave only limited access to healthcare. For that reason, countries have pled= ged to decrease the carbon footprint of their healthcare systems. www.hearingtracker.com Cheers, en bedankt! Jan-Willem ________________________________ Van: AUDITORY - Research in Auditory Perception <AUDITORY@xxxxxxxx> = namens Raul Sanchez <000001b89f1f4a81-dmarc-request@xxxxxxxx> Verzonden: zaterdag 5 november 2022 14:30 Aan: AUDITORY@xxxxxxxx <AUDITORY@xxxxxxxx> Onderwerp: Re: [AUDITORY] preprints, community journals, and the carbon foo= tprint of hearing healthcare U ontvangt niet vaak e-mail van 000001b89f1f4a81-dmarc-request@xxxxxxxx= .ca. Meer informatie over waarom dit belangrijk is<https://aka.ms/LearnAbou= tSenderIdentification> Hi Alejandro and Jan-Willem I absolutely agree with the uses of each platforms. Very helpful insights i= ndeed! For pre-registration I would add https://www.clinicaltrials.gov/<https://eu= r03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fwww.clinicaltrial= s.gov%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac08= 3eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnk= nown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJX= VCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DSk%2Bg8t7WzpLMlXAQwt50MSuDL1dZCykCqBkoBC= s5sPM%3D&reserved=3D0> and a quite interesting platform named: https://aspr= edicted.org/<https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A= %2F%2Faspredicted.org%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de030= 44c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C63803397= 0125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJB= TiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3Dx31tHJLoUdK30FFLeziKP876= DcOgu2KDIR5TtDWqbBc%3D&reserved=3D0> Also for data sharing, some journals allow to include data directly during = the submission in platforms such as https://figshare.com/<https://eur03.saf= elinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Ffigshare.com%2F&data=3D0= 5%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d= 4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3= d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000= %7C%7C%7C&sdata=3D1X1Rmck8szvxAflvJ9dez16SymSW8alVVmMJVCLWKGM%3D&reserved= =3D0>. One important aspect about preprints that we did not touch upon is =93when= =94 you can submit a preprint and not jeopardize your peer-review publicati= on. There are journals that only allow preprints before the submission to t= he journal (e.g. Alejandro could not upload a new version after acceptance = in those). The best way to know about it is with the Sherpa/Romeo: https:/= /v2.sherpa.ac.uk/romeo/<https://eur03.safelinks.protection.outlook.com/?url= =3Dhttps%3A%2F%2Fv2.sherpa.ac.uk%2Fromeo%2F&data=3D05%7C01%7Cd.baskent%40UM= CG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70= %7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiL= CJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3D6JN18= LShKzvhnBkVpgMC34JnLIFihoy3Cpt6t9Nn6lo%3D&reserved=3D0> There, you can see whether you can use preprints, and whether you can post = your accepted or copyedited version in your website or institutional reposi= tory. Best wishes Raul Sanchez-Lopez From: AUDITORY - Research in Auditory Perception <AUDITORY@xxxxxxxx>= On Behalf Of Alejandro Osses Sent: Saturday, 5 November 2022 06.02 To: AUDITORY@xxxxxxxx Subject: Re: [AUDITORY] preprints, community journals, and the carbon footp= rint of hearing healthcare Hoi Jan-Willem, These are very interesting questions. I just read Ra=FAl's answers with his= clarifications about these new ""publishing schemes", so my answer here is= based on my own experience about some of the platforms you mentioned (this= means that I am not answering directly to your questions). You mentioned BioRxiv, ArXiv, OSF, and Zenodo. I happened to have used all = these platforms and I actually use them for different purposes. * BioRxiv and ArXiv I use them to host preprints. I use BioRxiv if my p= aper contains collected behavioural data (human data from perceptual studie= s in my case), whereas I use ArXiv when I only use computational simulation= s as main component of my study. For both cases, I use them as a quick way = to generate the permanent identifier while I sumit the papers to a peer-rev= iewed journal. (Some of my examples: One of my papers from BioRxiv<https://= eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fwww.biorxiv.org= %2Fcontent%2F10.1101%2F2020.03.13.984542v1&data=3D05%7C01%7Cd.baskent%40UMC= G.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%= 7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLC= JQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DMKL88C= PVwrO%2Bj6bASL044HMxRAj5VnR3cYmhbjI2UOM%3D&reserved=3D0>; one of my ArXiv p= apers that has many versions<https://eur03.safelinks.protection.outlook.com= /?url=3Dhttps%3A%2F%2Farxiv.org%2Fabs%2F2107.01753&data=3D05%7C01%7Cd.baske= nt%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc= 20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLj= AwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata= =3D%2Fb73bLBoSNTC3L97iVQbj5qj7jYnqy3kJkCQ8mXFdhk%3D&reserved=3D0>) * OSF: I am using it now for my first pre-registered project. The idea = is to pre design your study and clearly state your hypothesis before you ru= n the actual study, in a way that if you get non-significant results or if = you reject some of your hypotheses you still pulish your study. This is a w= ay to avoid p-hacking. Of course OSF provides a permanent identifier for yo= ur project (I didn't realise it was a doi number), but my goal here is to c= ite the pre-registered document from OSF once my paper is finished and publ= ished (My current OSF project, I think is still embargoed: https://osf.io/4= ju3f/<https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fo= sf.io%2F4ju3f%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21e= b08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C6380339701252665= 07%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1h= aWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DnEN0R893P1AS%2FR6qNHYfwE6cRDXVzS= Wn6Eedbw5db6s%3D&reserved=3D0>) * Zenodo: I use it to host all binary data, meaning WAV files or any ot= her data that I cannot store using TXT files and codes from Python or MATLA= B and that are related to my study. Complementary to that, I linked Zenodo = to my Github, so that my "main codes" get tracked and obtain a doi number e= very time I make a new release of my software codes. This way "Zenodo Git"= and "Zenodo data" contain all the data I need to reproduce my paper data (= Zenodo linked to one of my Github MATLAB toolboxes<https://eur03.safelinks.= protection.outlook.com/?url=3Dhttps%3A%2F%2Fzenodo.org%2Frecord%2F6530154%2= 3.Y2X6zr7MJpg&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08= dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%= 7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWw= iLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DuUdzv1w26jln5OQVnmCIONtQ1Q3MS90oADu= rD2nie54%3D&reserved=3D0>; Zenodo containing just binary data for one of my= studies<https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%= 2Fzenodo.org%2Frecord%2F5483835%23.Y2X7XL7MJpg&data=3D05%7C01%7Cd.baskent%4= 0UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dd= e70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMD= AiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3Dbe= toR65EJ0vgSbO%2F2cW%2BQ3yfmkzWszwoOQfyu7q4fP0%3D&reserved=3D0>-the study wh= ere those data were used/cited is here<https://eur03.safelinks.protection.o= utlook.com/?url=3Dhttps%3A%2F%2Fhal.archives-ouvertes.fr%2Fhal-03345050v1&d= ata=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C33= 5122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125578521%7CUnknown%7CTWF= pbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D= %7C3000%7C%7C%7C&sdata=3DcpEO8p9BMd0okNvSU9BJ3evwVh6ePEOLdozdOipw1Mk%3D&res= erved=3D0>) I have used these platforms without peer review, but the idea is for me, to= always publish in a peer review journal soon after. My own papers have suf= fered big transformations during a couple of reviews. Therefore, I found it= somehow a "risk" that my first preprint versions are circulating. My worka= round is that, once a paper is published, I make a new final version of the= preprint, so that people who will download my preprint in the future will = not only see the link to the published paper (an automatic option from BioR= xiv and ArXiv), but if the press "download" they will get the most recent p= reprint version of the paper. Of course not every person sticks to these rules very strictly, so it can w= ell be that you run into papers that never got through a peer review (and a= re not planning to). To this extent BioRxiv and ArXiv may not be the best f= or relying 100% on what is hosted there. I hope the insights here are useful :) Success... Groetjes, Alejandro Op vr 4 nov. 2022 om 05:04 schreef Wasmann, Jan-Willem <Jan-Willem.Wasmann@xxxxxxxx= radboudumc.nl<mailto:Jan-Willem.Wasmann@xxxxxxxx>>: Dear list, Via this thread, I=92d like to touch upon preprints, community journals, an= d the carbon footprint of hearing healthcare. If you are in a hurry, please= skip this message TLDR. Otherwise, it would be great to tap into your coll= ective wisdom. In recent years, preprints have become increasingly popular to increase ope= n access. Some preprints get cited a lot (e.g., https://www.biorxiv.org/con= tent/10.1101/2021.10.04.463034v2.abstract<https://eur03.safelinks.protectio= n.outlook.com/?url=3Dhttps%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F20= 21.10.04.463034v2.abstract&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de0= 3044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033= 970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLC= JBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DGOB%2BHiTmPRHpURCdHChB= xUIX5%2BwJmsVig1M1PfuBaLI%3D&reserved=3D0> > 300 times). And especially in = AI, some preprints will probably never get peer-reviewed. A well-known exam= ple is: Saon G, Kurata G, Sercu T, Audhkhasi K, Thomas S, Dimitriadis D, et al. Eng= lish Conversational Telephone Speech Recognition by Humans and Machines. Ar= Xiv170302136 Cs (2017). Available online at: http://arxiv.org/<https://eur0= 3.safelinks.protection.outlook.com/?url=3Dhttp%3A%2F%2Farxiv.org%2F&data=3D= 05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9= d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb= 3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C300= 0%7C%7C%7C&sdata=3DobjDF2NKnXo2Qc1FyDyLp47TqCOrWKRNtxMX1dKuNNY%3D&reserved= =3D0> abs/1703.02136 There are multiple platforms to use. The most well-known is Biorxiv<https:/= /eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fwww.biorxiv.or= g%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083edd= f%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125578521%7CUnknown= %7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6= Mn0%3D%7C3000%7C%7C%7C&sdata=3DpgkDP3d5z5r%2Fdn6dw9MyHfpaYRnuT%2F08A3gHMDG7= bW8%3D&reserved=3D0> or Arxiv<https://eur03.safelinks.protection.outlook.co= m/?url=3Dhttps%3A%2F%2Farxiv.org%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7C= ee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0= %7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV= 2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DDURBFpByhUozF= KBBMPEXSTrsZlceuKavf%2BOcm0RWcD8%3D&reserved=3D0>. But also OSF<https://eur= 03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fosf.io%2Fpreprints= %2F%3Futm_term%3Dopen%2520science%2520framework%26utm_campaign%3DOSF%2BGene= ral%26utm_source%3Dadwords%26utm_medium%3Dppc%26hsa_acc%3D5222345373%26hsa_= cam%3D217339509%26hsa_grp%3D36452477753%26hsa_ad%3D150809658182%26hsa_src%3= Dg%26hsa_tgt%3Dkwd-300201585279%26hsa_kw%3Dopen%2520science%2520framework%2= 6hsa_mt%3Db%26hsa_net%3Dadwords%26hsa_ver%3D3%26gclid%3DEAIaIQobChMIp-_k7sG= R-wIVFweLCh2Sbw5YEAAYASAAEgIj7vD_BwE&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7= Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C= 0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoi= V2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DDotabiobQQT%= 2BAZH2ZkoUsYBSdmucB6XqtAxnO%2BLNnKE%3D&reserved=3D0> or Zenodo<https://eur0= 3.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fzenodo.org%2Frecord= %2F5600535%23.Y2NxnaSZOUk&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03= 044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C6380339= 70125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJ= BTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DLUabYLLUCJiXmnScH5vJWZ%= 2FLfjx9di64lcmER19wykY%3D&reserved=3D0>. I have used OSF since it has a bro= ad scope and allows you to upload projects. It provides a preprint DOI, whi= ch remains the same if you update the preprint at a later stage. Also, you = can link the DOI of the final peer-reviewed version of your paper. Zenodo c= an also be used for projects (data+paper), but every update will create a n= ew DOI. Q1a How do you regard the status of preprints? Q1b Is it a missed opportunity if one decides not to go for a peer-review p= rocess of a preprint? Another new development is open community-driven peer review procedures. I = found examples in other fields; see below. Q2a Do you know of examples of community-driven peer review in hearing scie= nces? Q2b Can you recommend a community-driven journal? Many scientists have responded to the new transparent consultative peer-rev= iew procedure by eLife (https://elifesciences.org/about/peer-review<https:/= /eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Felifesciences.= org%2Fabout%2Fpeer-review&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03= 044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C6380339= 70125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJ= BTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DwruMEqkd7fI%2F9p8Yqx5zY= 7QgsGp74K4mQwhVH%2F%2BvoDg%3D&reserved=3D0>). This might be an exciting ven= ue for those looking for new ways of peer review. However, the charges amou= nt to $2000. The charges for open access can be enormous (Nature $7000?) an= d a barrier for early career researchers. So far, I have found the following examples of community journal/peer revie= w processes: Pubpeer (The PubPeer Foundation is a California-registered public-benefit c= orporation with 501(c)(3) nonprofit status in the United States. The overar= ching goal of the Foundation is to improve the quality of scientific resear= ch by enabling innovative approaches for community interaction. The bylaws = of the Foundation establish pubpeer.com<https://eur03.safelinks.protection.= outlook.com/?url=3Dhttp%3A%2F%2Fpubpeer.com%2F&data=3D05%7C01%7Cd.baskent%4= 0UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dd= e70%7C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMD= AiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3D0d= 6of1yvSYdWSnyW68%2BCiyqqmhICvw9ICua2ZYhdtMM%3D&reserved=3D0> as a service r= un for the benefit of its readers and commenters, who create its content. O= ur current focus is maintaining and developing the PubPeer online platform = for post-publication peer review. https://pubpeer.com/static/about_<https:/= /eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fpubpeer.com%2F= static%2Fabout_&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb= 08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C63803397012557852= 1%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1ha= WwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3Dx2K6w2aWxASxbyi3v5gzo9jHNBv1wkDQ5= DKbQO39Xt8%3D&reserved=3D0>) Here you can find our preprint on that platform https://pubpeer.com/publications/AE2235B5F9F35577B977F87F9834B8<https://eur= 03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fpubpeer.com%2Fpubl= ications%2FAE2235B5F9F35577B977F87F9834B8&data=3D05%7C01%7Cd.baskent%40UMCG= .NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7= C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJ= QIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DqFqanTX= M5WRnDGmJrx6j4Ab9mWthUUq001sE4s1fk58%3D&reserved=3D0> It looks like an easy platform to use. It can be used for creating special = issues/collections (see https://pubpeer.com/publications/peeriodicals<https= ://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fpubpeer.com%= 2Fpublications%2Fpeeriodicals&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548= de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638= 033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzI= iLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DFk59N5nkUpNa8WJP4N3= I7AWbYdB65oxiPkSfooSmGjo%3D&reserved=3D0>). At the start, I had trouble reg= istering using my name/institution. An anonymous account was created quickl= y. Currently, PubPeer is used for post-publication review. I heard that in = other disciplines, Pubpeer is used to flag suspicious publications (read fr= aud). Another exciting example is ReviewCommons (Review Commons provides authors = with a Refereed Preprint, which includes the authors=92 manuscript, reports= from a single round of peer review and the authors=92 response. These Refe= reed Preprints are transferred on the author=92s behalf to bioRxiv. The mos= t recently-completed Review Commons peer-reviews are listed below, with the= most recently posted reviews at the top. https://www.reviewcommons.org/aut= hors/<https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fw= ww.reviewcommons.org%2Fauthors%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee= 1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7= C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2l= uMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3D6IzPSJNDwp3q3re= yHpc7kjv2oZquyb5JIjWahwmRDtY%3D&reserved=3D0>) Unfortunately, auditory sciences and audiology are not within the scope of = the peer-review initiative. The last example I know of is NBDT (NBDT is a community journal. If your ha= ndling editor sees it as in-scope it is appropriate. Editors are instructed= to only handle papers that they consider running as a journal club paper f= or their own lab https://nbdt.scholasticahq.com/for-authors<https://eur03.s= afelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fnbdt.scholasticahq.com= %2Ffor-authors&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb0= 8dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125578521= %7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haW= wiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DndozFQolL52DxtTLTtE2vaoDHBTdlP2zLs= it%2BJYTVxE%3D&reserved=3D0>). It=92s interesting to see their procedures, = including =93Can you propose reviewers? Short answer: no. Long answer: we d= id our own statistical analysis on a private dataset and have concluded tha= t it produces huge undesirable biases without leading to better reviews.=94 The Carbon Footprint of Hearing Healthcare With Jan de Laat, I have just written a perspective paper/blog about the Ca= rbon Footprint of Hearing Healthcare (see version 2, Preprint DOI 10.31219/= osf.io/3sj5u<https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A= %2F%2Fdoi.org%2F10.31219%2Fosf.io%2F3sj5u&data=3D05%7C01%7Cd.baskent%40UMCG= .NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7= C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJ= QIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DFW4vBGc= c%2Bgg01YzYBjQB%2FJTmJx5vebRxB8ValjLlLs4%3D&reserved=3D0>). The hearing tra= cker will publish the content today/tomorrow as a blog. So far, we have ext= racted information from ESG reports<https://eur03.safelinks.protection.outl= ook.com/?url=3Dhttps%3A%2F%2Fwww.pwc.com%2Fsk%2Fen%2Fenvironmental-social-a= nd-corporate-governance-esg%2Fesg-reporting.html&data=3D05%7C01%7Cd.baskent= %40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20= dde70%7C0%7C0%7C638033970125734743%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAw= MDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3D= SRvwS4JhpPmu3BCxRBTooHAz1rcKiMwHDdrcn5kzrWQ%3D&reserved=3D0> and our contac= ts within the hearing healthcare industry. Ideally, we would like to organi= ze a community-driven review process to collect comments from engineers, in= dustry, sustainability officers, authors from ESG reports, and scientists. Q3a What would be a suitable platform to organize and publish a community-d= riven review process of a perspective paper about carbon footprint in heari= ng healthcare? Another ambition could be to create a carbon footprint tracker of hearing h= ealthcare by annually updating table 1 from the preprint, including an asse= ssment of whether climate ambitions by industry were updated and achieved. Q3b What would be a suitable approach to annually monitor the carbon footpr= int of the hearing healthcare industry? (Maybe not peer-reviewed?) Please let me know what you think is the best community journal for auditor= y sciences. Don't hesitate to let us know if you believe opinion pieces sho= uldn=92t get into the review process. For me publishing this perspective pa= per is a low-risk experiment. If it goes well, I will consider submitting a= n original research manuscript. Thank you for your time. I am looking forward to your responses and advice. Best regards, Jan-Willem Wasmann De informatie in dit bericht is uitsluitend bestemd voor de geadresseerde. = Aan dit bericht en de bijlagen kunnen geen rechten worden ontleend. Heeft u= deze e-mail onbedoeld ontvangen? Dan verzoeken wij u het te vernietigen en= de afzender te informeren. Openbaar maken, kopi=EBren en verspreiden van d= eze e-mail of informatie uit deze e-mail is alleen toegestaan met voorafgaa= nde schriftelijke toestemming van de afzender. Het Radboudumc staat geregis= treerd bij de Kamer van Koophandel in het handelsregister onder nummer 8026= 2783. The content of this message is intended solely for the addressee. No rights= can be derived from this message or its attachments. If you are not the in= tended recipient, we kindly request you to delete the message and inform th= e sender. It is strictly prohibited to disclose, copy or distribute this em= ail or the information inside it, without a written consent from the sender= . Radboud university medical center is registered with the Dutch Chamber of= Commerce trade register with number 80262783. This message and any attachment are intended solely for the addressee and may contain confidential information. If you have received this message in error, please contact the sender and delete the email and attachment. Any views or opinions expressed by the author of this email do not necessarily reflect the views of the University of Nottingham. Email communications with the University of Nottingham may be monitored where permitted by law. De informatie in dit bericht is uitsluitend bestemd voor de geadresseerde. = Aan dit bericht en de bijlagen kunnen geen rechten worden ontleend. Heeft u= deze e-mail onbedoeld ontvangen? Dan verzoeken wij u het te vernietigen en= de afzender te informeren. Openbaar maken, kopi=EBren en verspreiden van d= eze e-mail of informatie uit deze e-mail is alleen toegestaan met voorafgaa= nde schriftelijke toestemming van de afzender. Het Radboudumc staat geregis= treerd bij de Kamer van Koophandel in het handelsregister onder nummer 8026= 2783. The content of this message is intended solely for the addressee. No rights= can be derived from this message or its attachments. If you are not the in= tended recipient, we kindly request you to delete the message and inform th= e sender. It is strictly prohibited to disclose, copy or distribute this em= ail or the information inside it, without a written consent from the sender= . Radboud university medical center is registered with the Dutch Chamber of= Commerce trade register with number 80262783. ________________________________ De inhoud van dit bericht is vertrouwelijk en alleen bestemd voor de geadre= sseerde(n). Anderen dan de geadresseerde(n) mogen geen gebruik maken van di= t bericht, het niet openbaar maken of op enige wijze verspreiden of vermeni= gvuldigen. Het UMCG kan niet aansprakelijk gesteld worden voor een incomple= te aankomst of vertraging van dit verzonden bericht. The contents of this message are confidential and only intended for the eye= s of the addressee(s). Others than the addressee(s) are not allowed to use = this message, to make it public or to distribute or multiply this message i= n any way. The UMCG cannot be held responsible for incomplete reception or = delay of this transferred message. --_000_PA4PR09MB4589C44F07DF831AC1D3018EE43C9PA4PR09MB4589eurp_ Content-Type: text/html; charset="windows-1250" Content-Transfer-Encoding: quoted-printable <html> <head> <meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dwindows-1= 250"> <style type=3D"text/css" style=3D"display:none;"> P {margin-top:0;margin-bo= ttom:0;} </style> </head> <body dir=3D"ltr"> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> Beste Jan-Willem, all,</div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> <br> </div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> This is a great discussion. It is very timely, addressing many important to= pics in one go.</div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> <br> </div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> For pre-registration and pre-printing:</div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> I agree that it is a great way to make known of a specific study and its re= lated hypotheses. This goes very well with open science principles. But we = did have suffer from pre-prints that have not made their way to a peer-revi= ewed publication because during a peer-review some substantial shortcomings were identified. Similarly, we= also have identified many times very important shortcomings of our own stu= dies/papers during peer-review, and at those times we were happy we did not= have a pre-print. Perhaps the best way to use them is to find out who works on what, but perhaps one should c= heck with the authors that the status is for the peer-review of a pre-print= before wanting to cite it. </div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> Having said that, especially for articles like yours, it would be great to = have a medium for opinion pieces. We did use one of these pre-registration = sites for this purpose, and once in awhile some journals (Frontiers?) also = allow articles like these.</div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> <br> </div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> About the carbon foot-print article:</div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> Very nice ideas! Having been in the fields of hearing aids and cochlear imp= lants for many years, I also have always wondered why the rechargeable batt= eries have not become that popular. Especially implant users have to rely o= n their batteries and if they use disposable ones, they need to remember to take many of them around to not = find themselves without their implant functioning. <br> Maybe also relevant: sometimes new device features or new approaches to sig= nal processing do not lead to an advantage in perception, but still produce= a benefit in power consumption. Sometimes such ideas are discarded, but an= ything that can lead to a longer battery life would be an important benefit for any device user.</div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> <br> </div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> Best wishes and groet,</div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> Deniz</div> <div style=3D"font-family: Calibri, Arial, Helvetica, sans-serif; font-size= : 10pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255);" class= =3D"elementToProof"> <br> </div> <div class=3D"elementToProof"> <div id=3D"Signature"> <div> <div dir=3D"ltr" style=3D"font-size:10pt; color:#000000; font-family:Calibr= i,Helvetica,sans-serif"> <div style=3D"font-family:Tahoma; font-size:13px"> <div style=3D"font-family:Tahoma; font-size:13px"> <div><font size=3D"2" face=3D"Tahoma"><span style=3D"font-size:10pt; font-f= amily:Calibri,Helvetica,sans-serif"></span></font></div> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif"></= span> <div><font size=3D"2" face=3D"Tahoma"><span><span><span style=3D"font-size:= 10pt; font-family:Calibri,Helvetica,sans-serif">--------------------------<= /span><br> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif">Pr= of. dr. ir. D. Ba=BAkent</span></span></span></font></div> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif"></= span> <div><font size=3D"2" face=3D"Tahoma"><span><span style=3D"font-size:10pt; = font-family:Calibri,Helvetica,sans-serif">Speech Perception Lab (dB SPL)<br= > </span></span></font> <div dir=3D"ltr" style=3D"color:rgb(32,33,36); font-family:Arial,Helvetica,= sans-serif"> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif">De= partment of Otorhinolaryngology</span><br> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif">Sc= hool of Behavioral and Cognitive Neuroscience (BCN)</span></div> <div dir=3D"ltr" style=3D"color:rgb(32,33,36); font-family:Arial,Helvetica,= sans-serif"> <span style=3D"color:black; font-family:Calibri,Helvetica,sans-serif; font-= size:10pt">W.J. Kolff Institute for Biomedical Engineering and Materials Sc= ience</span></div> <div dir=3D"ltr" style=3D"color:rgb(32,33,36); font-family:Arial,Helvetica,= sans-serif"> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif">Un= iversity Medical Center Groningen (UMCG)</span><br> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif">Un= iversity of Groningen (RUG)</span></div> <font size=3D"2" face=3D"Tahoma"><span><span style=3D"font-size:10pt; font-= family:Calibri,Helvetica,sans-serif">Tel: +31 (0) 50 3612540 (KNO Office)</= span></span></font></div> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif"></= span> <div><font size=3D"2" face=3D"Tahoma"><span><span><span id=3D"ms-rterangepa= ste-start"></span><span><span style=3D"font-size:10pt; font-family:Calibri,= Helvetica,sans-serif"></span> <div dir=3D"ltr"><span style=3D"font-size:10pt; font-family:Calibri,Helveti= ca,sans-serif">Visiting address: UMCG, Hanzeplein 1, Room P3.202</span><br> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif"></= span></div> <span style=3D"font-size:10pt; font-family:Calibri,Helvetica,sans-serif"></= span> <div dir=3D"ltr"><span style=3D"font-size:10pt; font-family:Calibri,Helveti= ca,sans-serif">Website (also for dB SPL): </span><a href=3D"http://dbaskent.org" target=3D"_blank"><span style=3D"fon= t-size:10pt; font-family:Calibri,Helvetica,sans-serif">dbaskent.org</span><= /a><font size=3D"2" face=3D"Tahoma"><span><span><span> </span><span id=3D"ms-rterangepaste-end"></span></span></span></font></div> </span></span></span></font></div> </div> </div> </div> </div> </div> </div> <div id=3D"signature_bookmark"></div> <div id=3D"appendonsend"></div> <div style=3D"font-family:Calibri,Arial,Helvetica,sans-serif; font-size:10p= t; color:rgb(0,0,0)"> <br> </div> <hr tabindex=3D"-1" style=3D"display:inline-block; width:98%"> <div id=3D"divRplyFwdMsg" dir=3D"ltr"><font face=3D"Calibri, sans-serif" co= lor=3D"#000000" style=3D"font-size:11pt"><b>From:</b> AUDITORY - Research i= n Auditory Perception <AUDITORY@xxxxxxxx> on behalf of Wasmann= , Jan-Willem <Jan-Willem.Wasmann@xxxxxxxx><br> <b>Sent:</b> 07 November 2022 6:42<br> <b>To:</b> AUDITORY@xxxxxxxx <AUDITORY@xxxxxxxx><br> <b>Subject:</b> Re: preprints, community journals, and the carbon footprint= of hearing healthcare</font> <div> </div> </div> <div dir=3D"ltr"> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> Dear Raul, goede morgen Alejandro and Bill,</div> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> Thank you for sharing these insights. </div> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> Raul you shared a number of platforms that are new to me. </div> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> Alejandro, it helps a lot that you shared your strategy and the different g= oals that you chase per platform. I like the GitHub integration of Zenodo.&= nbsp;<span style=3D"color:rgb(0,0,0); font-family:Calibri,Arial,Helvetica,s= ans-serif; font-size:12pt">I will digest this to revise my publishing strategy and will share it later here if peop= le are interested. Further suggestions are still welcome.</span></div> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> <br> </div> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> <span class=3D"x_ContentPasted0" style=3D"font-size:12pt; margin:0px; backg= round-color:rgb(255,255,255)">Bill shared some insights regarding the carbo= n footprint of chip design, re-use of medical devices and waste.</span><br = class=3D"x_ContentPasted0"> </div> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> Meanwhile, our little article/blog appeared here. We got excellent support = from the editors by the way from the Hearing Tracker and were glad we were = able to publish it before the COP27 started.</div> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> <br> </div> <div class=3D"x_elementToProof x_ContentPasted1" style=3D"font-family:Calib= ri,Arial,Helvetica,sans-serif; font-size:12pt; color:rgb(0,0,0); background= -color:rgb(255,255,255)"> <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fwww.hearingtracker.com%2Fnews%2Fcarbon-footprint-of-hearing-healthcare&= amp;data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf= %7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%= 7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6M= n0%3D%7C3000%7C%7C%7C&sdata=3DZ9HjE5dJ00xk3NUiymMSv5OnCLehyR8OrfjiJ2lG2= 3A%3D&reserved=3D0" data-auth=3D"Verified" originalsrc=3D"https://www.h= earingtracker.com/news/carbon-footprint-of-hearing-healthcare" shash=3D"b61= tbqlO8PPaaxt3ea0o0xxuzTxIN59+8XOi6HK8MSU4hFTiOityCM3e5QalZpriJvYH8SQ3uc3gjj= l4Eu3Jton3mcLshcFzwx3LMYxlfyqoS7e5eXN4+SSqCPvpNC2wKosb91ldjo1eFczb6j5TtUkhp= +eMID6lo8sM0duuOv8=3D" id=3D"LPlnkOWALinkPreview">https://www.hearingtracke= r.com/news/carbon-footprint-of-hearing-healthcare</a><br> </div> <div class=3D"x__Entity x__EType_OWALinkPreview x__EId_OWALinkPreview x__ER= eadonly_1"> <div id=3D"LPBorder_GTaHR0cHM6Ly93d3cuaGVhcmluZ3RyYWNrZXIuY29tL25ld3MvY2FyY= m9uLWZvb3RwcmludC1vZi1oZWFyaW5nLWhlYWx0aGNhcmU." class=3D"x_LPBorder999585"= style=3D"width:100%; margin-top:16px; margin-bottom:16px; max-width:800px;= min-width:424px"> <table id=3D"LPContainer999585" role=3D"presentation" style=3D"padding:12px= 36px 12px 12px; width:100%; border-width:1px; border-style:solid; border-c= olor:rgb(200,200,200); border-radius:2px"> <tbody> <tr valign=3D"top" style=3D"border-spacing:0px"> <td> <div id=3D"LPImageContainer999585" style=3D"margin-right:12px; height:135px= ; overflow:hidden; width:240px"> <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fwww.hearingtracker.com%2Fnews%2Fcarbon-footprint-of-hearing-healthcare&= amp;data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf= %7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%= 7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6M= n0%3D%7C3000%7C%7C%7C&sdata=3DZ9HjE5dJ00xk3NUiymMSv5OnCLehyR8OrfjiJ2lG2= 3A%3D&reserved=3D0" data-auth=3D"Verified" id=3D"LPImageAnchor999585" o= riginalsrc=3D"https://www.hearingtracker.com/news/carbon-footprint-of-heari= ng-healthcare" shash=3D"b61tbqlO8PPaaxt3ea0o0xxuzTxIN59+8XOi6HK8MSU4hFTiOit= yCM3e5QalZpriJvYH8SQ3uc3gjjl4Eu3Jton3mcLshcFzwx3LMYxlfyqoS7e5eXN4+SSqCPvpNC= 2wKosb91ldjo1eFczb6j5TtUkhp+eMID6lo8sM0duuOv8=3D"><img id=3D"LPThumbnailIma= geId999585" alt=3D"" height=3D"135" width=3D"240" style=3D"display:block" s= rc=3D"https://a.storyblok.com/f/45415/1200x675/c1db8bc00d/earth-and-carbon-= footprint-hearing-aid-industry_1200x675.jpg"></a></div> </td> <td style=3D"width:100%"> <div id=3D"LPTitle999585" style=3D"font-size:21px; font-weight:300; margin-= right:8px; font-family:wf_segoe-ui_light,"Segoe UI Light","S= egoe WP Light","Segoe UI","Segoe WP",Tahoma,Arial,= sans-serif; margin-bottom:12px"> <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fwww.hearingtracker.com%2Fnews%2Fcarbon-footprint-of-hearing-healthcare&= amp;data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf= %7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%= 7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6M= n0%3D%7C3000%7C%7C%7C&sdata=3DZ9HjE5dJ00xk3NUiymMSv5OnCLehyR8OrfjiJ2lG2= 3A%3D&reserved=3D0" data-auth=3D"Verified" id=3D"LPUrlAnchor999585" ori= ginalsrc=3D"https://www.hearingtracker.com/news/carbon-footprint-of-hearing= -healthcare" shash=3D"b61tbqlO8PPaaxt3ea0o0xxuzTxIN59+8XOi6HK8MSU4hFTiOityC= M3e5QalZpriJvYH8SQ3uc3gjjl4Eu3Jton3mcLshcFzwx3LMYxlfyqoS7e5eXN4+SSqCPvpNC2w= Kosb91ldjo1eFczb6j5TtUkhp+eMID6lo8sM0duuOv8=3D" style=3D"text-decoration:no= ne">The Carbon Footprint of Hearing Healthcare and How to Reduce It</a></div> <div id=3D"LPDescription999585" style=3D"font-size:14px; max-height:100px; = color:rgb(102,102,102); font-family:wf_segoe-ui_normal,"Segoe UI"= ,"Segoe WP",Tahoma,Arial,sans-serif; margin-bottom:12px; margin-r= ight:8px; overflow:hidden"> The global carbon footprint of medicine is about 5% of global CO 2 emission= s. 1-3 This is quite a chunk of our carbon budget to stay within 1.5=B0 C (= 2.7=B0F) of global warming, especially in light that many people globally h= ave only limited access to healthcare. For that reason, countries have pledged to decrease the carbon footprint o= f their healthcare systems.</div> <div id=3D"LPMetadata999585" style=3D"font-size:14px; font-weight:400; colo= r:rgb(166,166,166); font-family:wf_segoe-ui_normal,"Segoe UI",&qu= ot;Segoe WP",Tahoma,Arial,sans-serif"> www.hearingtracker.com</div> </td> </tr> </tbody> </table> </div> </div> <br> <div class=3D"x_elementToProof x_ContentPasted1" style=3D"font-family:Calib= ri,Arial,Helvetica,sans-serif; font-size:12pt; color:rgb(0,0,0); background= -color:rgb(255,255,255)"> Cheers, en bedankt!</div> <div class=3D"x_elementToProof x_ContentPasted1" style=3D"font-family:Calib= ri,Arial,Helvetica,sans-serif; font-size:12pt; color:rgb(0,0,0); background= -color:rgb(255,255,255)"> Jan-Willem</div> <div class=3D"x_elementToProof" style=3D"font-family:Calibri,Arial,Helvetic= a,sans-serif; font-size:12pt; color:rgb(0,0,0); background-color:rgb(255,25= 5,255)"> <span style=3D"font-size:12pt; margin:0px; background-color:rgb(255,255,255= )"></span><br> </div> <div id=3D"x_appendonsend"></div> <hr tabindex=3D"-1" style=3D"display:inline-block; width:98%"> <div id=3D"x_divRplyFwdMsg" dir=3D"ltr"><font face=3D"Calibri, sans-serif" = color=3D"#000000" style=3D"font-size:11pt" class=3D"elementToProof"><b>Van:= </b> AUDITORY - Research in Auditory Perception <AUDITORY@xxxxxxxx= A> namens Raul Sanchez <000001b89f1f4a81-dmarc-request@xxxxxxxx= A><br> <b>Verzonden:</b> zaterdag 5 november 2022 14:30<br> <b>Aan:</b> AUDITORY@xxxxxxxx <AUDITORY@xxxxxxxx><br> <b>Onderwerp:</b> Re: [AUDITORY] preprints, community journals, and the car= bon footprint of hearing healthcare</font> <div> </div> </div> <div lang=3D"EN-US" style=3D"word-wrap:break-word"> <table border=3D"0" cellspacing=3D"0" cellpadding=3D"0" width=3D"100%" alig= n=3D"left" style=3D"border:0; display:table; width:100%; table-layout:fixed= ; border-collapse:seperate; float:none"> <tbody style=3D"display:block"> <tr> <td valign=3D"middle" width=3D"1px" bgcolor=3D"#A6A6A6" cellpadding=3D"7px = 2px 7px 2px" style=3D"padding:7px 2px 7px 2px; background-color:#A6A6A6"> </td> <td valign=3D"middle" width=3D"100%" bgcolor=3D"#EAEAEA" cellpadding=3D"7px= 5px 7px 15px" color=3D"#212121" style=3D"width:100%; background-color:#EAE= AEA; padding:7px 5px 7px 15px; font-family:wf_segoe-ui_normal,Segoe UI,Sego= e WP,Tahoma,Arial,sans-serif; font-size:12px; font-weight:normal; color:#21= 2121; text-align:left; word-wrap:break-word"> <div>U ontvangt niet vaak e-mail van 000001b89f1f4a81-dmarc-request@xxxxxxxx= cgill.ca. <a href=3D"https://aka.ms/LearnAboutSenderIdentification" data-auth=3D"NotA= pplicable"> Meer informatie over waarom dit belangrijk is</a></div> </td> <td valign=3D"middle" align=3D"left" width=3D"75px" bgcolor=3D"#EAEAEA" cel= lpadding=3D"7px 5px 7px 5px" color=3D"#212121" style=3D"width:75px; backgro= und-color:#EAEAEA; padding:7px 5px 7px 5px; font-family:wf_segoe-ui_normal,= Segoe UI,Segoe WP,Tahoma,Arial,sans-serif; font-size:12px; font-weight:norm= al; color:#212121; text-align:left; word-wrap:break-word"> </td> </tr> </tbody> </table> <div> <div class=3D"x_x_WordSection1"> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Hi Alejandro and Jan-Willem</p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> I absolutely agree with the uses of each platforms. Very helpful insights i= ndeed!</p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> For pre-registration I would add <a href=3D"https://eur03.safelinks.protect= ion.outlook.com/?url=3Dhttps%3A%2F%2Fwww.clinicaltrials.gov%2F&data=3D0= 5%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d= 4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3= d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000= %7C%7C%7C&sdata=3DSk%2Bg8t7WzpLMlXAQwt50MSuDL1dZCykCqBkoBCs5sPM%3D&= reserved=3D0" data-auth=3D"Verified" originalsrc=3D"https://www.clinicaltri= als.gov/" shash=3D"QU3SAxxmleF2o9i/hYiRBTpLNmfbb86lwjy4zWzogCxNs1ThXTOLjJap= I2q8Vm9XZeJ0VH9G+s6zMd9JIpQJkM+UiL4fA4YGSTWDFXaiHEhrK4PhZCw+b5soC38VAjxGSnm= T1PF7Mt5vxEjgnXEHTLvJUEs/+cn7shAneTS10oI=3D"> https://www.clinicaltrials.gov/</a> and a quite interesting platform named:= <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%= 2F%2Faspredicted.org%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de= 03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C63803= 3970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiL= CJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3Dx31tHJLoUdK30FFLe= ziKP876DcOgu2KDIR5TtDWqbBc%3D&reserved=3D0" data-auth=3D"Verified" orig= inalsrc=3D"https://aspredicted.org/" shash=3D"v87vjGmLd7Wlmlq/NWOUmbpohngC1= LeRwS8dXQnxW5mX8u8CIC4zWGXd5pHry4c+jJIsZ+9dYAIxSNDTpnW7Sz+V790WnQ6q+JHUGb4u= w+C7itvFmRc3rbTRxn9bd0in339hj4FU/9KBdlJl+yHMcw0MTvA1EHYRzlE/cxw0Gfc=3D"> https://aspredicted.org/</a></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Also for data sharing, some journals allow to include data directly during = the submission in platforms such as <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Ffigshare.com%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de0304= 4c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970= 125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBT= iI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3D1X1Rmck8szvxAflvJ9dez= 16SymSW8alVVmMJVCLWKGM%3D&reserved=3D0" data-auth=3D"Verified" original= src=3D"https://figshare.com/" shash=3D"Qtc2622BgwBfJRAUAjAtv4PZ0zKdGYSR9dsG= 3xOxXOclMPVWnG/iraLP4DdrqqrbiV7g7mfxT3wZTsRjfZijOW1KSIQTXTD0UlnufySKmFFFa4H= fShnwx2ccs+7GYSPz4sXHtUyGAF188IFFgGnTvdrmRR/LyyRuXo/0ltT5sqA=3D"> https://figshare.com/</a>.</p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> One important aspect about preprints that we did not touch upon is =93when= =94 you can submit a preprint and not jeopardize your peer-review publicati= on. There are journals that only allow preprints before the submission to t= he journal (e.g. Alejandro could not upload a new version after acceptance in those). The best way to know abou= t it is with the Sherpa/Romeo: <a href=3D"https://eur03.safelinks.pro= tection.outlook.com/?url=3Dhttps%3A%2F%2Fv2.sherpa.ac.uk%2Fromeo%2F&dat= a=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C3351= 22f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpb= GZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7= C3000%7C%7C%7C&sdata=3D6JN18LShKzvhnBkVpgMC34JnLIFihoy3Cpt6t9Nn6lo%3D&a= mp;reserved=3D0" data-auth=3D"Verified" originalsrc=3D"https://v2.sherpa.ac= .uk/romeo/" shash=3D"alNK75Eeanw9DIpjPoYoDrKTavW362MuhJG/Dk/OCaOd3zcNDG144C= REtkt2j/BeFSf9m8jBA4Qp0399Yf+W5+60EblEYtc9P78/lu6OeC70514Z8dGdXW5vRqOkrpxnF= QqGGNn/SJ6NFwGA3iYRg3Bmh74QKEZTHxJ/Y0wOp98=3D">https://v2.sherpa.ac.uk/rome= o/</a></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> There, you can see whether you can use preprints, and whether you can post = your accepted or copyedited version in your website or institutional reposi= tory.</p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Best wishes</p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Raul Sanchez-Lopez</p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <div style=3D"border:none; border-top:solid #E1E1E1 1.0pt; padding:3.0pt 0c= m 0cm 0cm"> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> <b>From:</b> AUDITORY - Research in Auditory Perception <AUDITORY@xxxxxxxx= MCGILL.CA> <b>On Behalf Of </b>Alejandro Osses<br> <b>Sent:</b> Saturday, 5 November 2022 06.02<br> <b>To:</b> AUDITORY@xxxxxxxx<br> <b>Subject:</b> Re: [AUDITORY] preprints, community journals, and the carbo= n footprint of hearing healthcare</p> </div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Hoi Jan-Willem,</p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> These are very interesting questions. I just read Ra=FAl's answers with his= clarifications about these new ""publishing schemes", so my= answer here is based on my own experience about some of the platforms you = mentioned (this means that I am not answering directly to your questions).</p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> You mentioned BioRxiv, ArXiv, OSF, and Zenodo. I happened to have used all = these platforms and I actually use them for different purposes.</p> </div> <div> <ul type=3D"disc" style=3D"margin-bottom: 0cm;"> <li class=3D"x_x_MsoNormal" style=3D"margin: 0cm; font-size: 11pt; font-fam= ily: Calibri, sans-serif;"> BioRxiv and ArXiv I use them to host preprints. I use BioRxiv if my paper c= ontains collected behavioural data (human data from perceptual studies in m= y case), whereas I use ArXiv when I only use computational simulations as m= ain component of my study. For both cases, I use them as a quick way to generate the permanent identifier whil= e I sumit the papers to a peer-reviewed journal. (Some of my examples: One = of my papers from <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F2020.03.13.984542v1&data=3D05= %7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4= f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d= 8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%= 7C%7C%7C&sdata=3DMKL88CPVwrO%2Bj6bASL044HMxRAj5VnR3cYmhbjI2UOM%3D&r= eserved=3D0" data-auth=3D"Verified" originalsrc=3D"https://www.biorxiv.org/= content/10.1101/2020.03.13.984542v1" shash=3D"qjuvJ7v9m57MrHsjgjujscH3JCnLD= U5NzHlG7JnapdWH773WnEPCmMxHEBsFO+VqbxFdu63WG4JQbDSpNqJX+QcaAzHjDWYtI5LF++6r= 5D1EYTIr5vcv78Y1D65gQhhlHxLvhz6++YlCX/bc8UsX9I7gtfcg1VQjzQjgTvEXVDw=3D"> BioRxiv</a>; one of my <a href=3D"https://eur03.safelinks.protection.outloo= k.com/?url=3Dhttps%3A%2F%2Farxiv.org%2Fabs%2F2107.01753&data=3D05%7C01%= 7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67= a2fccd6dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWI= joiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%= 7C&sdata=3D%2Fb73bLBoSNTC3L97iVQbj5qj7jYnqy3kJkCQ8mXFdhk%3D&reserve= d=3D0" data-auth=3D"Verified" originalsrc=3D"https://arxiv.org/abs/2107.017= 53" shash=3D"N0jdJS25NKiH4GO8x7OVzcwUMv+ghuZCLc9gYZwZF0o6b7oSzUkgSNg6uq0lQ6= lzOsha0jhaPdGMFyQew73dJENeT3oj2OiYjqYcVMLqxAzXqe0voXvqL3MToa1B0dKzqHrhpGfJy= E1KtAKPE784yG1kjEIO/EZuhoqKmzTr+iI=3D"> ArXiv papers that has many versions</a>)</li><li class=3D"x_x_MsoNormal" st= yle=3D"margin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> OSF: I am using it now for my first pre-registered project. The idea is to = pre design your study and clearly state your hypothesis before you run the = actual study, in a way that if you get non-significant results or if you re= ject some of your hypotheses you still pulish your study. This is a way to avoid p-hacking. Of course OSF p= rovides a permanent identifier for your project (I didn't realise it was a = doi number), but my goal here is to cite the pre-registered document from O= SF once my paper is finished and published (My current OSF project, I think is still embargoed: <a href=3D"= https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fosf.io%= 2F4ju3f%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb0= 8dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125266507= %7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haW= wiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DnEN0R893P1AS%2FR6qNHYfwE6cRDXV= zSWn6Eedbw5db6s%3D&reserved=3D0" data-auth=3D"Verified" originalsrc=3D"= https://osf.io/4ju3f/" shash=3D"rDc+Gc72WyLia4JEXvWgjHlQrIHyibATZvUixtZ80zz= J2R/SdqsntpUw9/WB+rHnAcPOMTpHqRZsJ+6Gji03WzRoQjO80nHzDiNtacjIzFP26VAmcyVZbl= bJGItBRBnlIWxL/z8k3ZwTyMMbpdv9E9mziH5hpyXt5FeJXWo36xM=3D"> https://osf.io/4ju3f/</a>)</li><li class=3D"x_x_MsoNormal" style=3D"margin:= 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Zenodo: I use it to host all binary data, meaning WAV files or any other da= ta that I cannot store using TXT files and codes from Python or MATLAB and = that are related to my study. Complementary to that, I linked Zenodo to my = Github, so that my "main codes" get tracked and obtain a doi number every time I make a new release = of my software codes. This way "Zenodo Git" and "Zenodo data= " contain all the data I need to reproduce my paper data (Zenodo linke= d to one of my <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fzenodo.org%2Frecord%2F6530154%23.Y2X6zr7MJpg&data=3D05%7C01%7Cd.bas= kent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6= dc20dde70%7C0%7C0%7C638033970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4w= LjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&= sdata=3DuUdzv1w26jln5OQVnmCIONtQ1Q3MS90oADurD2nie54%3D&reserved=3D0" da= ta-auth=3D"Verified" originalsrc=3D"https://zenodo.org/record/6530154#.Y2X6= zr7MJpg" shash=3D"xFSSt8f6O02o9saCbDBWlpzxerf5k9q/w6XIHdbB8iw1PhXfw6cacf7u9= JDeH/VYOScNvwyXoGAG5aj9OrjDFOpDhZcnsoPJmLu40Fdfsdx9K13/Ky++ixFXum3pK1COHAz3= 51bVioR/cmQ6xIciv6P6b39j/6sxKTRbhgpvfSw=3D"> Github MATLAB toolboxes</a>; Zenodo containing just <a href=3D"https://eur0= 3.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fzenodo.org%2Frecord= %2F5483835%23.Y2X7XL7MJpg&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548= de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638= 033970125266507%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzI= iLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DbetoR65EJ0vgSbO= %2F2cW%2BQ3yfmkzWszwoOQfyu7q4fP0%3D&reserved=3D0" data-auth=3D"Verified= " originalsrc=3D"https://zenodo.org/record/5483835#.Y2X7XL7MJpg" shash=3D"T= fISt1WOcaYvT0a3GIIhYcfbytRDZ7sCkHsgX78HlHAXQ4uaE4LRZ1E8pw7m8fIqu1C/fbl8QK7r= /qdoyEhPqspJOQAR6GcXnFEOn9oEv/1aD+y2aTNN35MsEcefTyaEwwJta4ttnEqPNC8gAywO27b= IZvc9pqCzqsKd3lfKwLY=3D"> binary data for one of my studies</a>-the study where those data were used/= cited is <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fhal.archives-ouvertes.fr%2Fhal-03345050v1&data=3D05%7C01%7Cd.basken= t%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc2= 0dde70%7C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjA= wMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sda= ta=3DcpEO8p9BMd0okNvSU9BJ3evwVh6ePEOLdozdOipw1Mk%3D&reserved=3D0" data-= auth=3D"Verified" originalsrc=3D"https://hal.archives-ouvertes.fr/hal-03345= 050v1" shash=3D"GLjLjFCSMH92qmrHmn8gDaAw+jh6a361yeTahFDnia+lUuWh0XHP8X7VFzl= aWMpbrFNuw60TEgb6iyyrSID3vgUIXAg3HdWBS9TZFqpIf5V4HvSDx6rSowijKmD4U+SRBEAnS/= 0BhxylX8F+j7jqWgkNdg7f+/4GnDbv3Ck0CaU=3D"> here</a>)</li></ul> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> I have used these platforms without peer review, but the idea is for me, to= always publish in a peer review journal soon after. My own papers have suf= fered big transformations during a couple of reviews. Therefore, I found it= somehow a "risk" that my first preprint versions are circulating. My workaround is that, once a paper is = published, I make a new final version of the preprint, so that people who w= ill download my preprint in the future will not only see the link to the pu= blished paper (an automatic option from BioRxiv and ArXiv), but if the press "download" they will g= et the most recent preprint version of the paper.</p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Of course not every person sticks to these rules very strictly, so it can w= ell be that you run into papers that never got through a peer review (and a= re not planning to). To this extent BioRxiv and ArXiv may not be the best f= or relying 100% on what is hosted there. </p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> I hope the insights here are useful :)</p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Success...</p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Groetjes,</p> </div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Alejandro</p> </div> </div> </div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> </p> <div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;"> Op vr 4 nov. 2022 om 05:04 schreef Wasmann, Jan-Willem <<a href=3D"mailt= o:Jan-Willem.Wasmann@xxxxxxxx" data-auth=3D"NotApplicable">Jan-Willem.= Wasmann@xxxxxxxx</a>>:</p> </div> <blockquote style=3D"border:none; border-left:solid #CCCCCC 1.0pt; padding:= 0cm 0cm 0cm 6.0pt; margin-left:4.8pt; margin-right:0cm"> <div> <div> <div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Dear list, </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Via this thread, I=92d like t= o touch upon preprints, community journals, and the carbon footprint of hea= ring healthcare. If you are in a hurry, please skip this message TLDR. Othe= rwise, it would be great to tap into your collective wisdom. </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">In recent years, preprints ha= ve become increasingly popular to increase open access. Some preprints get = cited a lot (e.g., <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F2021.10.04.463034v2.abstract&= data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C3= 35122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125578521%7CUnknown%7CTW= FpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3= D%7C3000%7C%7C%7C&sdata=3DGOB%2BHiTmPRHpURCdHChBxUIX5%2BwJmsVig1M1PfuBa= LI%3D&reserved=3D0" data-auth=3D"Verified" originalsrc=3D"https://www.b= iorxiv.org/content/10.1101/2021.10.04.463034v2.abstract" shash=3D"gRIJiqWBa= HROISN/1ryV+60HSKSqArgH6leOki2eTakJA19LS6AaUHw2eq9xM9GxDeMs+vLoED3BCrx3RJ6s= O0ehrExJqL5RX8Bhc/PSy7W2j9zDSK2TW97bN013eobi4e/qq0xEScQSlOOVlFQ++MRHTRvf+AE= UVg0NkIwifz4=3D"> https://www.biorxiv.org/content/10.1101/2021.10.04.463034v2.abstract</a> &g= t; 300 times). And especially in AI, some preprints will probably never get= peer-reviewed. A well-known example is: </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;margin-left:35.= 4pt; background:white"> <span style=3D"font-size:12.0pt; color:black">Saon G, Kurata G, Sercu T, Au= dhkhasi K, Thomas S, Dimitriadis D, et al. English Conversational Telephone= Speech Recognition by Humans and Machines. ArXiv170302136 Cs (2017). Avail= able online at: <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttp%3A%2F= %2Farxiv.org%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f= 21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C6380339701255= 78521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6I= k1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DobjDF2NKnXo2Qc1FyDyLp47Tq= COrWKRNtxMX1dKuNNY%3D&reserved=3D0" data-auth=3D"Verified" originalsrc= =3D"http://arxiv.org/" shash=3D"VMLZ91y1U3Zid7f8VsxewRpNLiZUp72pWj31Yo2jMZt= 901nXlt0G+c178pMt3WB+pgm6ADmVHaTqSqWWE/uMU1IBuFGPnAxGAMgmhsClhKXi761+6toyra= p/YdrBKWZPNGxCvzWI0/2Ofy7y0tzpmVuW45izSmG8a3uXD6hiWRI=3D"> http://arxiv.org/</a> abs/1703.02136 </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">There are multiple platforms = to use. The most well-known is <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fwww.biorxiv.org%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de0= 3044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033= 970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLC= JBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DpgkDP3d5z5r%2Fdn6d= w9MyHfpaYRnuT%2F08A3gHMDG7bW8%3D&reserved=3D0" data-auth=3D"Verified" o= riginalsrc=3D"https://www.biorxiv.org/" shash=3D"mVgF2s3jPALmfe33NIE8o0M0jD= ujC1QYK8al9K868Ssg7Cd0MJG5/ocTV34kCV4ENJaIuTGu688NLkACGU6ZOdCZqZ1blfiqu+gHk= T27eLGRtyCZCNvwVlff8m6WVjsSov1mRwyMPakENaGlZrRvI1kdsTQA3sAESNoqSklm6jM=3D"> Biorxiv</a> or <a href=3D"https://eur03.safelinks.protection.outlook.com/?u= rl=3Dhttps%3A%2F%2Farxiv.org%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7C= ee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0= %7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV= 2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DDURBFpByh= UozFKBBMPEXSTrsZlceuKavf%2BOcm0RWcD8%3D&reserved=3D0" data-auth=3D"Veri= fied" originalsrc=3D"https://arxiv.org/" shash=3D"MWa+qbx7ZDL6UePZqGXIUDCaF= GJhQjhoeoXCsYlnvOe+PX1gFRnMxbVcAv+fCD9sI8yKJZhpatX+2z34eUVC+vh5mp9rG20FPlcB= bktozIg9ps8L/ku5Q52t4JEYbDuhjjUw4dPg7os8McBV7AcqnzKRG9tBXxWLCoUsOHchL0Q=3D"= > Arxiv</a>. But also <a href=3D"https://eur03.safelinks.protection.outlook.c= om/?url=3Dhttps%3A%2F%2Fosf.io%2Fpreprints%2F%3Futm_term%3Dopen%2520science= %2520framework%26utm_campaign%3DOSF%2BGeneral%26utm_source%3Dadwords%26utm_= medium%3Dppc%26hsa_acc%3D5222345373%26hsa_cam%3D217339509%26hsa_grp%3D36452= 477753%26hsa_ad%3D150809658182%26hsa_src%3Dg%26hsa_tgt%3Dkwd-300201585279%2= 6hsa_kw%3Dopen%2520science%2520framework%26hsa_mt%3Db%26hsa_net%3Dadwords%2= 6hsa_ver%3D3%26gclid%3DEAIaIQobChMIp-_k7sGR-wIVFweLCh2Sbw5YEAAYASAAEgIj7vD_= BwE&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083= eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125578521%7CUnkn= own%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXV= CI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DDotabiobQQT%2BAZH2ZkoUsYBSdmucB6XqtAx= nO%2BLNnKE%3D&reserved=3D0" data-auth=3D"Verified" originalsrc=3D"https= ://osf.io/preprints/?utm_term=3Dopen%20science%20framework&utm_campaign= =3DOSF+General&utm_source=3Dadwords&utm_medium=3Dppc&hsa_acc=3D= 5222345373&hsa_cam=3D217339509&hsa_grp=3D36452477753&hsa_ad=3D1= 50809658182&hsa_src=3Dg&hsa_tgt=3Dkwd-300201585279&hsa_kw=3Dope= n%20science%20framework&hsa_mt=3Db&hsa_net=3Dadwords&hsa_ver=3D= 3&gclid=3DEAIaIQobChMIp-_k7sGR-wIVFweLCh2Sbw5YEAAYASAAEgIj7vD_BwE" shas= h=3D"t2kXtMPrVkc/0OZlYoZCraHBOllgpten4ajlC6nDmoUtxQpCznYlXEV9a2+ee+V+ZSHLBW= DzJxZ3Zb92Z6lF89KI35igXs6fe94lN4JmNl5HAS+b0JEGEvqZTm9S+L1YeORNheR1dLokjsAe7= p3fFGpNv1EBQzgrGHZi4GzFJf0=3D"> OSF</a> or <a href=3D"https://eur03.safelinks.protection.outlook.com/?url= =3Dhttps%3A%2F%2Fzenodo.org%2Frecord%2F5600535%23.Y2NxnaSZOUk&data=3D05= %7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4= f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d= 8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%= 7C%7C%7C&sdata=3DLUabYLLUCJiXmnScH5vJWZ%2FLfjx9di64lcmER19wykY%3D&r= eserved=3D0" data-auth=3D"Verified" originalsrc=3D"https://zenodo.org/recor= d/5600535#.Y2NxnaSZOUk" shash=3D"nMXuCAs/nIzYW51PUHyJSBsG0nAsQ3agSs5HeJD7ak= c1jtoaC8dMYFw60ESIK5V6DLBvHCJZ7UY6q0dqe974LqlyWMsSTGNzRaTDaAFDgdhFKOGwsp49a= Bvr/m/e0Ffqmzsrw+3vkaDsoamkvg6quatV8vk3VpAVzGERzPzn3bE=3D"> Zenodo</a>. I have used OSF since it has a broad scope and allows you to up= load projects. It provides a preprint DOI, which remains the same if you up= date the preprint at a later stage. Also, you can link the DOI of the final= peer-reviewed version of your paper. Zenodo can also be used for projects (data+paper), but every update will c= reate a new DOI. </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <b><span style=3D"font-size:12.0pt; color:black">Q1a How do you regard the = status of preprints? </span></b><span style=3D"font-size:12.0pt; color= :black"></span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <b><span style=3D"font-size:12.0pt; color:black">Q1b Is it a missed opportu= nity if one decides not to go for a peer-review process of a preprint? = ;</span></b><span style=3D"font-size:12.0pt; color:black"></span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Another new development is op= en community-driven peer review procedures. I found examples in other field= s; see below. </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <b><span style=3D"font-size:12.0pt; color:black">Q2a Do you know of example= s of community-driven peer review in hearing sciences? </span></b><sp= an style=3D"font-size:12.0pt; color:black"></span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <b><span style=3D"font-size:12.0pt; color:black">Q2b Can you recommend a co= mmunity-driven journal? </span></b><span style=3D"font-size:12.0pt; co= lor:black"></span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Many scientists have responde= d to the new transparent consultative peer-review procedure by eLife (<a hr= ef=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fe= lifesciences.org%2Fabout%2Fpeer-review&data=3D05%7C01%7Cd.baskent%40UMC= G.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%= 7C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLC= JQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3Dwr= uMEqkd7fI%2F9p8Yqx5zY7QgsGp74K4mQwhVH%2F%2BvoDg%3D&reserved=3D0" data-a= uth=3D"Verified" originalsrc=3D"https://elifesciences.org/about/peer-review= " shash=3D"VKiWcOoBeq+Ad6RazSvYjepAyAcJYJqO+S6W7eRQY9RXlVfpl9icCiA5Husv6Y1g= 86aYWF1uLj/YORqWjPtS+mCmAZPw9xcLGp8hWqQfeXRDAKyESzJr2Jw5uhYflXjiuPHsOw+lK3e= 9LNtXPBMT8BF9OXI0tIXZA6IJMU2OAtI=3D">https://elifesciences.org/about/peer-r= eview</a>). This might be an exciting venue for those looking for new ways of peer rev= iew. However, the charges amount to $2000. The charges for open access can = be enormous (Nature $7000?) and a barrier for early career researchers.&nbs= p;</span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">So far, I have found the foll= owing examples of community journal/peer review processes: </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Pubpeer (</span><span style= =3D"font-size:11.5pt; font-family:"Source Sans Pro",sans-serif; c= olor:#676A6C; background:white">The <strong><span style=3D"font-family= :"Source Sans Pro",sans-serif">PubPeer</span></strong> Found= ation </span><i><span style=3D"font-size:12.0pt; color:black">is a California-reg= istered public-benefit corporation with 501(c)(3) nonprofit status in the U= nited States. The overarching goal of the Foundation is to improve the qual= ity of scientific research by enabling innovative approaches for community interaction. The bylaws of the Foundat= ion establish <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttp%3A%2F= %2Fpubpeer.com%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c= 5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C63803397012= 5578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI= 6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3D0d6of1yvSYdWSnyW68%2BCi= yqqmhICvw9ICua2ZYhdtMM%3D&reserved=3D0" data-auth=3D"Verified" original= src=3D"http://pubpeer.com/" shash=3D"s+eTOzAZ16jN1G5UT/hBISTiwNOwDl2/ZVgxk/= OuhozPuIaG/21ymN7AYhFZKrQeHO6qDoCcBqCOL9DmFmw16W3hf8PUs0nnO65WLEzpmfx1WQ2oF= gQZ65InvRch5NtRVMdflfanI+HZdke/Lepv8CA0z5FTIAiVFIlNZzNnNnA=3D"> pubpeer.com</a> as a service run for the benefit of its readers and comment= ers, who create its content. Our current focus is maintaining and developin= g the <b>PubPeer</b> online platform for post-publication peer re= view</span></i><span style=3D"font-size:11.5pt; font-family:"Source Sa= ns Pro",sans-serif; color:#676A6C; background:white">. <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fpubpeer.com%2Fstatic%2Fabout_&data=3D05%7C01%7Cd.baskent%40UMCG.NL%= 7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7= C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjo= iV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3Dx2K6w2a= WxASxbyi3v5gzo9jHNBv1wkDQ5DKbQO39Xt8%3D&reserved=3D0" data-auth=3D"Veri= fied" originalsrc=3D"https://pubpeer.com/static/about_" shash=3D"IdC66M5lce= IGF5IFQfGZ09C9YOiSzOcQx4AigB2EUxEqYDCTpYuldryh4+DOUGUQdTlzOK9I6pziDNRttiKCF= 9DsCD9kHRGnMyX+CeKmgJRnN2rTE4hJKD3oFJ/0d+cpnppjFORnb9fT6OF1/w67bjzcOpdvdz0X= yDic66tnodg=3D"> https://pubpeer.com/static/about_</a>)</span><span style=3D"font-size:12.0p= t; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Here you can find our preprin= t on that platform </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"><a href=3D"https://eur03.safe= links.protection.outlook.com/?url=3Dhttps%3A%2F%2Fpubpeer.com%2Fpublication= s%2FAE2235B5F9F35577B977F87F9834B8&data=3D05%7C01%7Cd.baskent%40UMCG.NL= %7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%= 7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIj= oiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DqFqanT= XM5WRnDGmJrx6j4Ab9mWthUUq001sE4s1fk58%3D&reserved=3D0" data-auth=3D"Ver= ified" originalsrc=3D"https://pubpeer.com/publications/AE2235B5F9F35577B977= F87F9834B8" shash=3D"ZyqpTZLWE4fadW1fShsPuMrkU2GV2pfWoyAhNUDqpVbZMtDkTKoICf= 0Na7b3/aBi/2Q/qQpZ2mH8Zu5RSRNwxWJF7MKiLwv9jMjQ5fCQWR9bgSxtzhWB4hDn+sKtA+lvc= Cidl6HtR+itq/kymBuKtrrWlBNqg+oI09jmfygo/s4=3D">https://pubpeer.com/publicat= ions/AE2235B5F9F35577B977F87F9834B8</a> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">It looks like an easy platfor= m to use. It can be used for creating special issues/collections (see <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fpubpeer.com%2Fpublications%2Fpeeriodicals&data=3D05%7C01%7Cd.basken= t%40UMCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc2= 0dde70%7C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjA= wMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sda= ta=3DFk59N5nkUpNa8WJP4N3I7AWbYdB65oxiPkSfooSmGjo%3D&reserved=3D0" data-= auth=3D"Verified" originalsrc=3D"https://pubpeer.com/publications/peeriodic= als" shash=3D"F4zCRFecUe9f3iMxJFgRmfBObvZ0FsFYZp++nElVrPuv9s4vfZv05erSAkFy/= fF28y3s3foP75uaRCfDqtgQZ7b9CUd6q0kLcUUA2WQhsuR4BM083kKn0JpYTKv6bTbDOzXsgmF1= ba+4ELdhioj4yNsH+IEwK+KalmpHFPjEQuw=3D"> https://pubpeer.com/publications/peeriodicals</a>). At the start, I had tro= uble registering using my name/institution. An anonymous account was create= d quickly. Currently, PubPeer is used for post-publication review. I heard = that in other disciplines, Pubpeer is used to flag suspicious publications (read fraud). </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Another exciting example is R= eviewCommons (</span><em><span style=3D"font-size:12.0pt; font-family:Lora;= color:#2D2D2D; background:white">Review Commons</span></em><span style=3D"= font-size:12.0pt; font-family:Lora; color:#2D2D2D; background:white"> = </span><i><span style=3D"font-size:12.0pt; color:black">provides authors with a Refereed Preprint, which includes the authors=92 manuscript= , reports from a single round of peer review and the authors=92 response. T= hese Refereed Preprints are transferred on the author=92s behalf to bioRxiv= . The most recently-completed Review Commons peer-reviews are listed below, with the most recently posted reviews at th= e top</span></i><span style=3D"font-size:12.0pt; font-family:Lora; color:#2= D2D2D; background:white">. </span><span style=3D"font-size:12.0pt; color:black"><a href=3D"https://eur= 03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Fwww.reviewcommons.= org%2Fauthors%2F&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de03044c5= f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C638033970125= 578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6= Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3D6IzPSJNDwp3q3reyHpc7kjv2= oZquyb5JIjWahwmRDtY%3D&reserved=3D0" data-auth=3D"Verified" originalsrc= =3D"https://www.reviewcommons.org/authors/" shash=3D"rEFnEC82FzszkvXgP/2w9G= WHb9JgwJqszBzElEsKotIUXCTRySH0w2DQC3iqcHOBDJaMj7kMvAWTVYnzYYL2P9ezvBHlKia5o= n1GhOpuigGGOymKwproBn3pEF5L1BdnDlNkem54fnyNgZ4x7Z37zKAbbxIwEzm5WwTgWVAQ2SM= =3D">https://www.reviewcommons.org/authors/</a>) </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Unfortunately, auditory scien= ces and audiology are not within the scope of the peer-review initiative.&n= bsp;</span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">The last example I know of is= NBDT (NBDT <i>is a community journal. If your handling editor sees it as in-scope it i= s appropriate. Editors are instructed to only handle papers that they consi= der running as a journal club paper for their own lab</i> <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fnbdt.scholasticahq.com%2Ffor-authors&data=3D05%7C01%7Cd.baskent%40U= MCG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde7= 0%7C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAi= LCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3D= ndozFQolL52DxtTLTtE2vaoDHBTdlP2zLsit%2BJYTVxE%3D&reserved=3D0" data-aut= h=3D"Verified" originalsrc=3D"https://nbdt.scholasticahq.com/for-authors" s= hash=3D"ShvlmBfMEFZi36HBcE5w5gdxeL4umrJ/JCSmiLWT9bD8uqfaFwD/8w3Mk7FuA0z5lcY= tSMU3+so+a2LMNrI2GLG/TaPQxuLw3lGxjec8isWNqPZbpH13M1eqs4fK0drOCS2d/0f7ywizQ5= n8r+LvvI6QMqA6VFLBMFMRkzmqZ6o=3D"> https://nbdt.scholasticahq.com/for-authors</a>). It=92s interesting to see = their procedures, including =93<b>Can you propose reviewers?</b> Short= answer: no. Long answer: we did our own statistical analysis on a private = dataset and have concluded that it produces huge undesirable biases without leading to better reviews.=94 </span>= </p> <div style=3D"border:none; border-bottom:solid windowtext 1.0pt; padding:0c= m 0cm 1.0pt 0cm; border-color:currentcolor currentcolor windowtext"> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> </div> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">The Carbon Footprint of Heari= ng Healthcare </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black; background:white">With Jan de= Laat, </span><span style=3D"font-size:12.0pt; color:black">I have jus= t written a perspective paper/blog about the Carbon Footprint of Hearing He= althcare (see version 2, Preprint DOI <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fdoi.org%2F10.31219%2Fosf.io%2F3sj5u&data=3D05%7C01%7Cd.baskent%40UM= CG.NL%7Cee1548de03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70= %7C0%7C0%7C638033970125578521%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiL= CJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DF= W4vBGcc%2Bgg01YzYBjQB%2FJTmJx5vebRxB8ValjLlLs4%3D&reserved=3D0" data-au= th=3D"Verified" originalsrc=3D"https://doi.org/10.31219/osf.io/3sj5u" shash= =3D"oLn5onKSNPWui7hppevWVSR4tBASyBxCkYqqK332kfjHP77hEk3ika/MbhAQsUP4/TAig2y= 7NUIYWK/cHtAA0ZxfhXl/oTc0uLd50lAfPOU8uzhOoYHFEn4cfIWVfXdZorVIHrHIaOk3aj1QcX= aBTPCwolaY4a5Ejhp53apDQf8=3D"> 10.31219/osf.io/3sj5u</a>). The hearing tracker will publish the content to= day/tomorrow as a blog. So far, we have extracted information from <a href=3D"https://eur03.safelinks.protection.outlook.com/?url=3Dhttps%3A%2= F%2Fwww.pwc.com%2Fsk%2Fen%2Fenvironmental-social-and-corporate-governance-e= sg%2Fesg-reporting.html&data=3D05%7C01%7Cd.baskent%40UMCG.NL%7Cee1548de= 03044c5f21eb08dac083eddf%7C335122f9d4f44d67a2fccd6dc20dde70%7C0%7C0%7C63803= 3970125734743%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiL= CJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=3DSRvwS4JhpPmu3BCxR= BTooHAz1rcKiMwHDdrcn5kzrWQ%3D&reserved=3D0" data-auth=3D"Verified" orig= inalsrc=3D"https://www.pwc.com/sk/en/environmental-social-and-corporate-gov= ernance-esg/esg-reporting.html" shash=3D"B0Qf9L5BcrH3dtaggbJaQwv+mlDhlGVINW= 5cELUsmr+6LGSNQNemnnxZ+X3LIvuEoL+0eN/9sdlIxHMMzv0/dnrz7/VpM7g8YQsHvWO24mVa2= esOT/NgEpyQ7kGBEAdIVkT0WdH5imk76DYf2JEcduxpWzJMITpzvOvHoPgE+XU=3D"> ESG reports</a> and our contacts within the hearing healthcare industry. Id= eally, we would like to organize a community-driven review process to colle= ct comments from engineers, industry, sustainability officers, authors from= ESG reports, and scientists. </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <b><span style=3D"font-size:12.0pt; color:black">Q3a What would be a suitab= le platform to organize and publish a community-driven review process of a = perspective paper about carbon footprint in hearing healthcare? </spa= n></b><span style=3D"font-size:12.0pt; color:black"></span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Another ambition could be to = create a carbon footprint tracker of hearing healthcare by annually updatin= g table 1 from the preprint, including an assessment of whether climate amb= itions by industry were updated and achieved. </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <b><span style=3D"font-size:12.0pt; color:black">Q3b What would be a suitab= le approach to annually monitor the carbon footprint of the hearing healthc= are industry? </span></b><span style=3D"font-size:12.0pt; color:black">(Maybe not peer-re= viewed?)<b> </b></span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Please let me know what you t= hink is the best community journal for auditory sciences. Don't hesitate to= let us know if you believe opinion pieces shouldn=92t get into the review = process. For me publishing this perspective paper is a low-risk experiment. If it goes well, I will consider submittin= g an original research manuscript. </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Thank you for your time. I am= looking forward to your responses and advice. </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Best regards, </span></p= > <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black">Jan-Willem Wasmann </sp= an></p> <p class=3D"x_x_MsoNormal" style=3D"margin-top: 0px; margin-bottom: 0px;mar= gin: 0cm; font-size: 11pt; font-family: Calibri, sans-serif;background:whit= e"> <span style=3D"font-size:12.0pt; color:black"> </span></p> </div> <p style=3D"margin-top: 0px; margin-bottom: 0px;"><i><span style=3D"font-si= ze:10.0pt; font-family:"Arial",sans-serif">De informatie in dit b= ericht is uitsluitend bestemd voor de geadresseerde. Aan dit bericht en de = bijlagen kunnen geen rechten worden ontleend. Heeft u deze e-mail onbedoeld ontvangen? Dan verzoeken wij u het te vernie= tigen en de afzender te informeren. Openbaar maken, kopi=EBren en verspreid= en van deze e-mail of informatie uit deze e-mail is alleen toegestaan met v= oorafgaande schriftelijke toestemming van de afzender. Het Radboudumc staat geregistreerd bij de Kamer van Kooph= andel in het handelsregister onder nummer 80262783.<br> <br> The content of this message is intended solely for the addressee. No rights= can be derived from this message or its attachments. If you are not the in= tended recipient, we kindly request you to delete the message and inform th= e sender. It is strictly prohibited to disclose, copy or distribute this email or the information inside it, w= ithout a written consent from the sender. Radboud university medical center= is registered with the Dutch Chamber of Commerce trade register with numbe= r 80262783. </span></i></p> </div> </div> </blockquote> </div> </div> <pre>This message and any attachment are intended solely for the addressee= =0A= and may contain confidential information. If you have received this=0A= message in error, please contact the sender and delete the email and=0A= attachment. =0A= =0A= Any views or opinions expressed by the author of this email do not=0A= necessarily reflect the views of the University of Nottingham. Email=0A= communications with the University of Nottingham may be monitored =0A= where permitted by law.=0A= =0A= =0A= =0A= </pre> </div> </div> <p style=3D"margin-top: 0px; margin-bottom: 0px;font-size:13px; font-style:= italic; font-family:arial"> De informatie in dit bericht is uitsluitend bestemd voor de geadresseerde. = Aan dit bericht en de bijlagen kunnen geen rechten worden ontleend. Heeft u= deze e-mail onbedoeld ontvangen? Dan verzoeken wij u het te vernietigen en= de afzender te informeren. Openbaar maken, kopi=EBren en verspreiden van deze e-mail of informatie uit deze e-= mail is alleen toegestaan met voorafgaande schriftelijke toestemming van de= afzender. Het Radboudumc staat geregistreerd bij de Kamer van Koophandel i= n het handelsregister onder nummer 80262783.<br> <br> The content of this message is intended solely for the addressee. No rights= can be derived from this message or its attachments. If you are not the in= tended recipient, we kindly request you to delete the message and inform th= e sender. It is strictly prohibited to disclose, copy or distribute this email or the information inside it, w= ithout a written consent from the sender. Radboud university medical center= is registered with the Dutch Chamber of Commerce trade register with numbe= r 80262783. <br> </p> </div> <hr> De inhoud van dit bericht is vertrouwelijk en alleen bestemd voor de geadre= sseerde(n). Anderen dan de geadresseerde(n) mogen geen gebruik maken van di= t bericht, het niet openbaar maken of op enige wijze verspreiden of vermeni= gvuldigen. Het UMCG kan niet aansprakelijk gesteld worden voor een incomplete aankomst of vertraging van dit verzonde= n bericht. <br> <br> The contents of this message are confidential and only intended for the eye= s of the addressee(s). Others than the addressee(s) are not allowed to use = this message, to make it public or to distribute or multiply this message i= n any way. The UMCG cannot be held responsible for incomplete reception or delay of this transferred message. </body> </html> --_000_PA4PR09MB4589C44F07DF831AC1D3018EE43C9PA4PR09MB4589eurp_--